C14orf138 Inhibitors
C14orf138 is a protein whose activity can be influenced by a variety of chemical inhibitors, each targeting distinct signaling pathways or biological processes with which C14orf138 may be associated. These inhibitors operate on the premise that C14orf138 plays a role within specific cellular contexts, such as growth factor signaling, cell cycle regulation, or stress response pathways. For example, compounds that disrupt the PI3K/AKT or MAPK/ERK pathways would indirectly lead to the inhibition of C14orf138 assuming it is a regulatory component or a downstream effector in these pathways. By halting the phosphorylation events or protein synthesis that C14orf138 may require for its function, these inhibitors can effectively reduce its activity within the cell. Similarly, given C14orf138 is implicated in the cellular response to stress, molecules that inhibit the p38 MAP kinase would dampen the pathway's response, diminishing the functional activity of C14orf138.
Moreover, the inhibition of key kinases involved in cell cycle progression, such as Aurora kinases, and the disruption of microtubule dynamics by specific compounds, could lead to an indirect inhibition of C14orf138 if it is involved in mitotic events. Additionally, inhibitors that target calcium signaling or affect cytoskeletal dynamics can impede C14orf138's activity by altering intracellular calcium levels or cell motility, respectively. For instance, given C14orf138's activity is contingent upon calcium-dependent signaling, the inhibition of calcium ATPases would result in an inhibition of C14orf138. Likewise, assuming C14orf138 is associated with actin dynamics or cell migration, ROCK inhibitors could suppress its activity by modulating the actin cytoskeleton.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin specifically binds to and inhibits mTOR (mammalian target of rapamycin), which is a central molecule in regulating cell growth and metabolism. By inhibiting mTOR, rapamycin can decrease protein synthesis and cell proliferation, leading to reduced expression or activity of C14orf138. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including PKC. PKC is involved in various signaling pathways that regulate numerous cellular functions, such as proliferation and survival. Assuming C14orf138's function is regulated by PKC-mediated phosphorylation, staurosporine may indirectly inhibit C14orf138's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a selective inhibitor of MEK1 and MEK2, enzymes upstream of ERK in the MAPK/ERK pathway. Inhibition of this pathway can prevent the phosphorylation and activation of ERK, which may decrease the functional activity of C14orf138 assuming it is an ERK substrate or is regulated by ERK-mediated signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a chemical inhibitor of PI3K, which can prevent the activation of AKT, downstream of PI3K. The downstream effects of AKT inhibition could lead to reduced functional activity of C14orf138. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a selective inhibitor of p38 MAP kinase. By inhibiting p38, this compound interferes with the cellular response to stress and cytokines. Assuming C14orf138 is involved in stress or cytokine signaling that is dependent on p38 MAPK, its activity may be decreased by SB203580. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
2-Methoxyestradiol inhibits microtubule polymerization, which affects cell division and can induce apoptosis. Assuming C14orf138 plays a role in cell cycle progression or survival, its function could be indirectly inhibited by 2-Methoxyestradiol through disruption of microtubule dynamics. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor, which affects the regulation of mitosis. Assuming C14orf138 is involved in mitotic progression or cytokinesis, inhibition of Aurora kinases could lead to a decrease in C14orf138 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sesquiterpene lactone that inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). By disrupting calcium homeostasis, thapsigargin could indirectly inhibit C14orf138. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated protein kinase (ROCK). Inhibition of ROCK can lead to alterations in the cytoskeleton and cellular motility. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that targets several receptor tyrosine kinases (RTKs) involved in tumor growth and angiogenesis. Assuming C14orf138 is part of signaling cascades that are initiated by these RTKs, its activity could be inhibited by sorafenib. | ||||||